APO Research
Talk to an analyst

APO RESEARCH · REPORT

Candida Infection Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Candida Infection Testing Market Analysis and Forecast 2026-2032

3 May 2026200 pages

Choose your research edition.

Industry ResearchCandida Infection Testing Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Candida Infection Testing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Candida Infection Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candida Infection Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Candida Infection Testing Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Candida Infection Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Candida Infection Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Candida Infection Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Candida Infection Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Candida Infection Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Candida Infection Testing include Roche Diagnostics, Abbott Diagnostics, bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Siemens Healthineers, Bruker, Danaher and QuidelOrtho, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Candida Infection Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Candida Infection Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Candida Infection Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Candida Infection Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Candida Infection Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Candida Infection Testing revenue, projected growth trends, production technology, application and end-user industry.

Candida Infection Testing Segment by Company

Roche Diagnostics

Abbott Diagnostics

bioMérieux

Becton Dickinson

Thermo Fisher Scientific

Siemens Healthineers

Bruker

Danaher

QuidelOrtho

Luminex

Hologic

Sysmex

Bio‑Rad Laboratories

Cepheid

Qiagen

ARUP Laboratories

Labcorp

Quest Diagnostics

Eurofins Scientific

Synlab

Candida Infection Testing Segment by Type

Traditional Culture

Molecular Biology Detection

Candida Infection Testing Segment by Application

Medical

Maternal and Child Health

Physical Examination

Aesthetic Medicine

Other

Candida Infection Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candida Infection Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candida Infection Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candida Infection Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Candida Infection Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Candida Infection Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Candida Infection Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Candida Infection Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Traditional Culture Major Player Table 3. Molecular Biology Detection Major Player Table 4. Global Candida Infection Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Major Player Table 6. Maternal and Child Health Major Player Table 7. Physical Examination Major Player Table 8. Aesthetic Medicine Major Player Table 9. Other Major Player Table 10. Candida Infection Testing Industry Trends Table 11. Candida Infection Testing Industry Drivers Table 12. Candida Infection Testing Industry Opportunities and Challenges Table 13. Candida Infection Testing Industry Restraints Table 14. Global Candida Infection Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Candida Infection Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Candida Infection Testing Market Share by Region (2021-2026) Table 17. Global Candida Infection Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Candida Infection Testing Market Share by Region (2027-2032) Table 19. Global Candida Infection Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Candida Infection Testing Revenue Market Share by Players (2021-2026) Table 21. Global Candida Infection Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Candida Infection Testing Key Players Headquarters & Area Served Table 23. Global Candida Infection Testing Players, Product Type & Application Table 24. Global Candida Infection Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Candida Infection Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Candida Infection Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Candida Infection Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Candida Infection Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Candida Infection Testing Revenue Market Share by Type (2021-2026) Table 31. Global Candida Infection Testing Revenue Market Share by Type (2027-2032) Table 32. Global Candida Infection Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Candida Infection Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Candida Infection Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Candida Infection Testing Revenue Market Share by Application (2021-2026) Table 36. Global Candida Infection Testing Revenue Market Share by Application (2027-2032) Table 37. Roche Diagnostics Company Information Table 38. Roche Diagnostics Business Overview Table 39. Roche Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Roche Diagnostics Candida Infection Testing Product Portfolio Table 41. Roche Diagnostics Recent Development Table 42. Abbott Diagnostics Company Information Table 43. Abbott Diagnostics Business Overview Table 44. Abbott Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Abbott Diagnostics Candida Infection Testing Product Portfolio Table 46. Abbott Diagnostics Recent Development Table 47. bioMérieux Company Information Table 48. bioMérieux Business Overview Table 49. bioMérieux Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. bioMérieux Candida Infection Testing Product Portfolio Table 51. bioMérieux Recent Development Table 52. Becton Dickinson Company Information Table 53. Becton Dickinson Business Overview Table 54. Becton Dickinson Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Becton Dickinson Candida Infection Testing Product Portfolio Table 56. Becton Dickinson Recent Development Table 57. Thermo Fisher Scientific Company Information Table 58. Thermo Fisher Scientific Business Overview Table 59. Thermo Fisher Scientific Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Thermo Fisher Scientific Candida Infection Testing Product Portfolio Table 61. Thermo Fisher Scientific Recent Development Table 62. Siemens Healthineers Company Information Table 63. Siemens Healthineers Business Overview Table 64. Siemens Healthineers Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Siemens Healthineers Candida Infection Testing Product Portfolio Table 66. Siemens Healthineers Recent Development Table 67. Bruker Company Information Table 68. Bruker Business Overview Table 69. Bruker Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bruker Candida Infection Testing Product Portfolio Table 71. Bruker Recent Development Table 72. Danaher Company Information Table 73. Danaher Business Overview Table 74. Danaher Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Danaher Candida Infection Testing Product Portfolio Table 76. Danaher Recent Development Table 77. QuidelOrtho Company Information Table 78. QuidelOrtho Business Overview Table 79. QuidelOrtho Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. QuidelOrtho Candida Infection Testing Product Portfolio Table 81. QuidelOrtho Recent Development Table 82. Luminex Company Information Table 83. Luminex Business Overview Table 84. Luminex Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Luminex Candida Infection Testing Product Portfolio Table 86. Luminex Recent Development Table 87. Hologic Company Information Table 88. Hologic Business Overview Table 89. Hologic Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Hologic Candida Infection Testing Product Portfolio Table 91. Hologic Recent Development Table 92. Sysmex Company Information Table 93. Sysmex Business Overview Table 94. Sysmex Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Sysmex Candida Infection Testing Product Portfolio Table 96. Sysmex Recent Development Table 97. Bio‑Rad Laboratories Company Information Table 98. Bio‑Rad Laboratories Business Overview Table 99. Bio‑Rad Laboratories Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Bio‑Rad Laboratories Candida Infection Testing Product Portfolio Table 101. Bio‑Rad Laboratories Recent Development Table 102. Cepheid Company Information Table 103. Cepheid Business Overview Table 104. Cepheid Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Cepheid Candida Infection Testing Product Portfolio Table 106. Cepheid Recent Development Table 107. Qiagen Company Information Table 108. Qiagen Business Overview Table 109. Qiagen Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Qiagen Candida Infection Testing Product Portfolio Table 111. Qiagen Recent Development Table 112. ARUP Laboratories Company Information Table 113. ARUP Laboratories Business Overview Table 114. ARUP Laboratories Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. ARUP Laboratories Candida Infection Testing Product Portfolio Table 116. ARUP Laboratories Recent Development Table 117. Labcorp Company Information Table 118. Labcorp Business Overview Table 119. Labcorp Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Labcorp Candida Infection Testing Product Portfolio Table 121. Labcorp Recent Development Table 122. Quest Diagnostics Company Information Table 123. Quest Diagnostics Business Overview Table 124. Quest Diagnostics Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Quest Diagnostics Candida Infection Testing Product Portfolio Table 126. Quest Diagnostics Recent Development Table 127. Eurofins Scientific Company Information Table 128. Eurofins Scientific Business Overview Table 129. Eurofins Scientific Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Eurofins Scientific Candida Infection Testing Product Portfolio Table 131. Eurofins Scientific Recent Development Table 132. Synlab Company Information Table 133. Synlab Business Overview Table 134. Synlab Candida Infection Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Synlab Candida Infection Testing Product Portfolio Table 136. Synlab Recent Development Table 137. North America Candida Infection Testing Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Candida Infection Testing Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Candida Infection Testing Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Candida Infection Testing Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Candida Infection Testing Revenue by Country (2021-2026) & (US$ Million) Table 143. North America Candida Infection Testing Revenue by Country (US$ Million) & (2027-2032) Table 144. Europe Candida Infection Testing Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Candida Infection Testing Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Candida Infection Testing Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Candida Infection Testing Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Candida Infection Testing Revenue by Country (2021-2026) & (US$ Million) Table 150. Europe Candida Infection Testing Revenue by Country (US$ Million) & (2027-2032) Table 151. China Candida Infection Testing Revenue by Type (2021-2026) & (US$ Million) Table 152. China Candida Infection Testing Revenue by Type (2027-2032) & (US$ Million) Table 153. China Candida Infection Testing Revenue by Application (2021-2026) & (US$ Million) Table 154. China Candida Infection Testing Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Candida Infection Testing Revenue by Type (2021-2026) & (US$ Million) Table 156. Asia Candida Infection Testing Revenue by Type (2027-2032) & (US$ Million) Table 157. Asia Candida Infection Testing Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Candida Infection Testing Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Candida Infection Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Candida Infection Testing Revenue by Region (US$ Million) & (2021-2026) Table 161. Asia Candida Infection Testing Revenue by Region (US$ Million) & (2027-2032) Table 162. SAMEA Candida Infection Testing Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Candida Infection Testing Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Candida Infection Testing Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Candida Infection Testing Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Candida Infection Testing Revenue by Country (2021-2026) & (US$ Million) Table 168. SAMEA Candida Infection Testing Revenue by Country (US$ Million) & (2027-2032) Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Candida Infection Testing Image Figure 2. Global Candida Infection Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Candida Infection Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Traditional Culture Image Figure 5. Molecular Biology Detection Image Figure 6. Global Candida Infection Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Candida Infection Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Image Figure 9. Maternal and Child Health Image Figure 10. Physical Examination Image Figure 11. Aesthetic Medicine Image Figure 12. Other Image Figure 13. Global Candida Infection Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global Candida Infection Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Candida Infection Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Candida Infection Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Candida Infection Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Candida Infection Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Candida Infection Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Candida Infection Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Candida Infection Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Candida Infection Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Candida Infection Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Candida Infection Testing Revenue Share by Type (2021-2032) Figure 26. North America Candida Infection Testing Revenue Share by Application (2021-2032) Figure 27. North America Candida Infection Testing Revenue Share by Country (2021-2032) Figure 28. United States Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Candida Infection Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Candida Infection Testing Revenue Share by Type (2021-2032) Figure 33. Europe Candida Infection Testing Revenue Share by Application (2021-2032) Figure 34. Europe Candida Infection Testing Revenue Share by Country (2021-2032) Figure 35. Germany Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Candida Infection Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Candida Infection Testing Revenue Share by Type (2021-2032) Figure 45. China Candida Infection Testing Revenue Share by Application (2021-2032) Figure 46. Asia Candida Infection Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Candida Infection Testing Revenue Share by Type (2021-2032) Figure 48. Asia Candida Infection Testing Revenue Share by Application (2021-2032) Figure 49. Asia Candida Infection Testing Revenue Share by Region (2021-2032) Figure 50. Japan Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Candida Infection Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Candida Infection Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA Candida Infection Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA Candida Infection Testing Revenue Share by Country (2021-2032) Figure 60. Brazil Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Candida Infection Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Culture
  • Molecular Biology Detection
Applications
  • Medical
  • Maternal and Child Health
  • Physical Examination
  • Aesthetic Medicine
  • Other
Companies covered
  • Roche Diagnostics
  • Abbott Diagnostics
  • bioMérieux
  • Becton Dickinson
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Bruker
  • Danaher
  • QuidelOrtho
  • Luminex
  • Hologic
  • Sysmex
  • Bio‑Rad Laboratories
  • Cepheid
  • Qiagen
  • ARUP Laboratories
  • Labcorp
  • Quest Diagnostics
  • Eurofins Scientific
  • Synlab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Candida Infection Testing Market by Type
  3. 1.2.1 Global Candida Infection Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Traditional Culture
  5. 1.2.3 Molecular Biology Detection
  6. 1.3 Candida Infection Testing Market by Application
  7. 1.3.1 Global Candida Infection Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical
  9. 1.3.3 Maternal and Child Health
  10. 1.3.4 Physical Examination
  11. 1.3.5 Aesthetic Medicine
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Candida Infection Testing Market Dynamics
  1. 2.1 Candida Infection Testing Industry Trends
  2. 2.2 Candida Infection Testing Industry Drivers
  3. 2.3 Candida Infection Testing Industry Opportunities and Challenges
  4. 2.4 Candida Infection Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Candida Infection Testing Market Perspective (2021-2032)
  2. 3.2 Global Candida Infection Testing Growth Trends by Region
  3. 3.2.1 Global Candida Infection Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Candida Infection Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Candida Infection Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Candida Infection Testing Revenue by Players
  2. 4.1.1 Global Candida Infection Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Candida Infection Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Candida Infection Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Candida Infection Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Candida Infection Testing Key Players Headquarters & Area Served
  7. 4.4 Global Candida Infection Testing Players, Product Type & Application
  8. 4.5 Global Candida Infection Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Candida Infection Testing Market CR5 and HHI
  11. 4.6.3 2025 Candida Infection Testing Tier 1, Tier 2, and Tier 3
5 Candida Infection Testing Market Size by Type
  1. 5.1 Global Candida Infection Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Candida Infection Testing Revenue by Type (2021-2032)
  3. 5.3 Global Candida Infection Testing Revenue Market Share by Type (2021-2032)
6 Candida Infection Testing Market Size by Application
  1. 6.1 Global Candida Infection Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Candida Infection Testing Revenue by Application (2021-2032)
  3. 6.3 Global Candida Infection Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche Diagnostics
  2. 7.1.1 Roche Diagnostics Company Information
  3. 7.1.2 Roche Diagnostics Business Overview
  4. 7.1.3 Roche Diagnostics Candida Infection Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Diagnostics Candida Infection Testing Product Portfolio
  6. 7.1.5 Roche Diagnostics Recent Developments
  7. 7.2 Abbott Diagnostics
  8. 7.2.1 Abbott Diagnostics Company Information
  9. 7.2.2 Abbott Diagnostics Business Overview
  10. 7.2.3 Abbott Diagnostics Candida Infection Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Diagnostics Candida Infection Testing Product Portfolio
  12. 7.2.5 Abbott Diagnostics Recent Developments
  13. 7.3 bioMérieux
  14. 7.3.1 bioMérieux Company Information
  15. 7.3.2 bioMérieux Business Overview
  16. 7.3.3 bioMérieux Candida Infection Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 bioMérieux Candida Infection Testing Product Portfolio
  18. 7.3.5 bioMérieux Recent Developments
  19. 7.4 Becton Dickinson
  20. 7.4.1 Becton Dickinson Company Information
  21. 7.4.2 Becton Dickinson Business Overview
  22. 7.4.3 Becton Dickinson Candida Infection Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Becton Dickinson Candida Infection Testing Product Portfolio
  24. 7.4.5 Becton Dickinson Recent Developments
  25. 7.5 Thermo Fisher Scientific
  26. 7.5.1 Thermo Fisher Scientific Company Information
  27. 7.5.2 Thermo Fisher Scientific Business Overview
  28. 7.5.3 Thermo Fisher Scientific Candida Infection Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Scientific Candida Infection Testing Product Portfolio
  30. 7.5.5 Thermo Fisher Scientific Recent Developments
  31. 7.6 Siemens Healthineers
  32. 7.6.1 Siemens Healthineers Company Information
  33. 7.6.2 Siemens Healthineers Business Overview
  34. 7.6.3 Siemens Healthineers Candida Infection Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Siemens Healthineers Candida Infection Testing Product Portfolio
  36. 7.6.5 Siemens Healthineers Recent Developments
  37. 7.7 Bruker
  38. 7.7.1 Bruker Company Information
  39. 7.7.2 Bruker Business Overview
  40. 7.7.3 Bruker Candida Infection Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bruker Candida Infection Testing Product Portfolio
  42. 7.7.5 Bruker Recent Developments
  43. 7.8 Danaher
  44. 7.8.1 Danaher Company Information
  45. 7.8.2 Danaher Business Overview
  46. 7.8.3 Danaher Candida Infection Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Danaher Candida Infection Testing Product Portfolio
  48. 7.8.5 Danaher Recent Developments
  49. 7.9 QuidelOrtho
  50. 7.9.1 QuidelOrtho Company Information
  51. 7.9.2 QuidelOrtho Business Overview
  52. 7.9.3 QuidelOrtho Candida Infection Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 QuidelOrtho Candida Infection Testing Product Portfolio
  54. 7.9.5 QuidelOrtho Recent Developments
  55. 7.10 Luminex
  56. 7.10.1 Luminex Company Information
  57. 7.10.2 Luminex Business Overview
  58. 7.10.3 Luminex Candida Infection Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Luminex Candida Infection Testing Product Portfolio
  60. 7.10.5 Luminex Recent Developments
  61. 7.11 Hologic
  62. 7.11.1 Hologic Company Information
  63. 7.11.2 Hologic Business Overview
  64. 7.11.3 Hologic Candida Infection Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Hologic Candida Infection Testing Product Portfolio
  66. 7.11.5 Hologic Recent Developments
  67. 7.12 Sysmex
  68. 7.12.1 Sysmex Company Information
  69. 7.12.2 Sysmex Business Overview
  70. 7.12.3 Sysmex Candida Infection Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sysmex Candida Infection Testing Product Portfolio
  72. 7.12.5 Sysmex Recent Developments
  73. 7.13 Bio‑Rad Laboratories
  74. 7.13.1 Bio‑Rad Laboratories Company Information
  75. 7.13.2 Bio‑Rad Laboratories Business Overview
  76. 7.13.3 Bio‑Rad Laboratories Candida Infection Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bio‑Rad Laboratories Candida Infection Testing Product Portfolio
  78. 7.13.5 Bio‑Rad Laboratories Recent Developments
  79. 7.14 Cepheid
  80. 7.14.1 Cepheid Company Information
  81. 7.14.2 Cepheid Business Overview
  82. 7.14.3 Cepheid Candida Infection Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cepheid Candida Infection Testing Product Portfolio
  84. 7.14.5 Cepheid Recent Developments
  85. 7.15 Qiagen
  86. 7.15.1 Qiagen Company Information
  87. 7.15.2 Qiagen Business Overview
  88. 7.15.3 Qiagen Candida Infection Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Qiagen Candida Infection Testing Product Portfolio
  90. 7.15.5 Qiagen Recent Developments
  91. 7.16 ARUP Laboratories
  92. 7.16.1 ARUP Laboratories Company Information
  93. 7.16.2 ARUP Laboratories Business Overview
  94. 7.16.3 ARUP Laboratories Candida Infection Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 ARUP Laboratories Candida Infection Testing Product Portfolio
  96. 7.16.5 ARUP Laboratories Recent Developments
  97. 7.17 Labcorp
  98. 7.17.1 Labcorp Company Information
  99. 7.17.2 Labcorp Business Overview
  100. 7.17.3 Labcorp Candida Infection Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Labcorp Candida Infection Testing Product Portfolio
  102. 7.17.5 Labcorp Recent Developments
  103. 7.18 Quest Diagnostics
  104. 7.18.1 Quest Diagnostics Company Information
  105. 7.18.2 Quest Diagnostics Business Overview
  106. 7.18.3 Quest Diagnostics Candida Infection Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Quest Diagnostics Candida Infection Testing Product Portfolio
  108. 7.18.5 Quest Diagnostics Recent Developments
  109. 7.19 Eurofins Scientific
  110. 7.19.1 Eurofins Scientific Company Information
  111. 7.19.2 Eurofins Scientific Business Overview
  112. 7.19.3 Eurofins Scientific Candida Infection Testing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Eurofins Scientific Candida Infection Testing Product Portfolio
  114. 7.19.5 Eurofins Scientific Recent Developments
  115. 7.20 Synlab
  116. 7.20.1 Synlab Company Information
  117. 7.20.2 Synlab Business Overview
  118. 7.20.3 Synlab Candida Infection Testing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Synlab Candida Infection Testing Product Portfolio
  120. 7.20.5 Synlab Recent Developments
8 North America
  1. 8.1 North America Candida Infection Testing Revenue (2021-2032)
  2. 8.2 North America Candida Infection Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Candida Infection Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Candida Infection Testing Revenue by Type (2027-2032)
  5. 8.3 North America Candida Infection Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Candida Infection Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Candida Infection Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Candida Infection Testing Revenue by Application (2027-2032)
  9. 8.5 North America Candida Infection Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Candida Infection Testing Revenue by Country
  11. 8.6.1 North America Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Candida Infection Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Candida Infection Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Candida Infection Testing Revenue (2021-2032)
  2. 9.2 Europe Candida Infection Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Candida Infection Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Candida Infection Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Candida Infection Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Candida Infection Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Candida Infection Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Candida Infection Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Candida Infection Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Candida Infection Testing Revenue by Country
  11. 9.6.1 Europe Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Candida Infection Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Candida Infection Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Candida Infection Testing Revenue (2021-2032)
  2. 10.2 China Candida Infection Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Candida Infection Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Candida Infection Testing Revenue by Type (2027-2032)
  5. 10.3 China Candida Infection Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Candida Infection Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Candida Infection Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Candida Infection Testing Revenue by Application (2027-2032)
  9. 10.5 China Candida Infection Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Candida Infection Testing Revenue (2021-2032)
  2. 11.2 Asia Candida Infection Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Candida Infection Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Candida Infection Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Candida Infection Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Candida Infection Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Candida Infection Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Candida Infection Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Candida Infection Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Candida Infection Testing Revenue by Country
  11. 11.6.1 Asia Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Candida Infection Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Candida Infection Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Candida Infection Testing Revenue (2021-2032)
  2. 12.2 SAMEA Candida Infection Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Candida Infection Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Candida Infection Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Candida Infection Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Candida Infection Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Candida Infection Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Candida Infection Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Candida Infection Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Candida Infection Testing Revenue by Country
  11. 12.6.1 SAMEA Candida Infection Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Candida Infection Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Candida Infection Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst